EN6
EN6 has been studied in 3 papers since 2025: none in people yet, 3 in animals; 2 in the past year. The research so far is in animals.
At a glance
The findings reach mice, none yet in people. 2 independent labs in 2 countries.
None of its findings points the other way.
Mice: a single group. Cells, worms or flies and humans: nothing yet.
- 2 independent labs in 2 countries
- Funders: Astellas Foundation for Research on Metabolic Disorders and others
- Animals2
What did studies of EN6 find?
2Studies of EN6 measured 2 outcomes: cellular senescence and pancreatic cancer.
Cellular senescence
downin mice1
1 study
Cellular senescence
downin mice1
EN6 decreases cellular senescence in Rnasek-/- mouse embryos.
Animalsin Rnasek-/- mouse embryos
Pancreatic cancer
downin mice1
1 study
Pancreatic cancer
downin mice1
EN6 prevents pancreatic cancer in xenograft and Kras mutant mouse models.
Animalsin xenograft and Kras mutant mouse models
Latest
1 paper in 12 monthsNature Communications
Senescence-associated lysosomal dysfunction impairs cystine deprivation-induced lipid peroxidation and ferroptosis
Experiments in miceFerroptosis